Hepatotoxicity in drug development: detection, significance and solutions.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0168-8278(97)80494-1PMID 9204407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of non-genotoxic carcinogenesis.

  1994cited by this paper
• Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis

  1994cited by this paper
• An Examination of the Drug Review Process Within the United States

  1994cited by this paper
• Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin

  1994cited by this paper
• Current Knowledge of Mechanisms of Carcinogenicity: Genotoxins versus Non-genotoxins

  1994cited by this paper
• Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol.

  1994cited by this paper
• Image analysis of bromodeoxyuridine (BrdU) staining for measurement of S-phase in rat and mouse liver.

  1994cited by this paper
• Safety Assessment Programs for U.S. Regulatory Agencies: A Perspective of Requirements and Compliance

  1994cited by this paper
• Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs.

  1994cited by this paper
• Risks, regulation, and rewards in new drug development in the United States.

  1994cited by this paper
• Carcinogenicity of TCDD: experimental, mechanistic, and epidemiologic evidence.

  1994cited by this paper
• Retrospective assessment of liver cell proliferation via PCNA: a comparison with tritiated thymidine.

  1994cited by this paper
• The Use of the Dog in Toxicity Tests on Pharmaceutical Compounds

  1993cited by this paper
• Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac.

  1993cited by this paper
• Concepts, labeling procedures, and design of cell proliferation studies relating to carcinogenesis.

  1993cited by this paper
• Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets.

  1993cited by this paper
• An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes.

  1993cited by this paper
• Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury.

  1993cited by this paper
• Correlation of metabolism, covalent binding and toxicity for a series of bromobenzene derivatives using rat liver slices in vitro.

  1993cited by this paper
• Effect of bile acids on intracellular calcium in isolated rat hepatocyte couplets.

  1993cited by this paper
• Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.

  1993cited by this paper
• Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats.

  1993cited by this paper
• Use of cell proliferation data in cancer risk assessment: FDA view.

  1993cited by this paper
• The concept of multispecies testing in industrial toxicology.

  1993cited by this paper
• The integration of investigative toxicology in the drug discovery process

  1993cited by this paper
• The dioxin and peroxisome proliferator-activated receptors: nuclear receptors in search of endogenous ligands.

  1992cited by this paper
• Actin filament alteration as a potential marker for cholestasis: a study in isolated rat hepatocyte couplets.

  1992cited by this paper
• UDP-glucuronosyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism.

  1992cited by this paper
• Nuclear receptors and chemical carcinogenesis.

  1992cited by this paper
• Role of covalent and noncovalent interactions in cell toxicity: effects on proteins.

  1992cited by this paper
• Cell death by apoptosis and its protective role against disease.

  1992cited by this paper
• Phenobarbital induction of cytochrome P-450 gene expression.

  1992cited by this paper
• Chemical Structure-Activity Relationships: Peroxisome Proliferation and Lipid Regulation in Rats

  1992cited by this paper
• Structure-Based Strategies for Drug Design and Discovery

  1992cited by this paper
• Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium

  1991cited by this paper
• Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery

  1991cited by this paper
• Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium.

  1991cited by this paper
• Guidelines for measuring chemically induced cell proliferation in specific rodent target organs.

  1991cited by this paper
• Predictive value of animal studies in toxicology.

  1991cited by this paper
• Animal Toxicity Studies: Their Relevance for Man

  1991cited by this paper
• Stimulation of hepatocyte DNA synthesis by ethinyl estradiol.

  1991cited by this paper
• The role of experimental toxicology in safety evaluation: Challenges facing the pharmaceutical industry

  1990cited by this paper
• Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals.

  1990cited by this paper
• Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.

  1990cited by this paper
• Early Phase Drug Evaluation in Man

  1990cited by this paper
• Precision-cut liver slices: an in vitro system for profiling potential hepatotoxicants

  1990cited by this paper
• Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors.

  1990cited by this paper
• Biochemical mechanisms of induction of hepatic peroxisome proliferation.

  1989cited by this paper
• Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.

  1989cited by this paper
• The Significance of Hepatic Microsomal Enzyme Induction and Altered Thyroid Function in Rats: Implications for Thyroid Gland Neoplasia

  1989cited by this paper
• Reactive intermediates and their toxicological significance.

  1988cited by this paper
• Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins.

  1988cited by this paper
• Preclinical evaluation of lovastatin.

  1988cited by this paper
• Predicting the safety of medicines from animal toxicity tests. I. Rodents alone.

  1987cited by this paper
• Immunochemical detection of acetaminophen-bound liver proteins.

  1987cited by this paper
• Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.

  1987cited by this paper
• Predicting the safety of medicines from animal toxicity tests. II. Rodents and non-rodents.

  1987cited by this paper
• Isolated and cultured hepatocytes

  1986cited by this paper
• Drug-induced Hepatic Injury

  1985cited by this paper
• Natural plant chemicals: sources of industrial and medicinal materials.

  1985cited by this paper
• Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters.

  1984cited by this paper
• Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.

  1983cited by this paper
• New applications of microbial products.

  1983cited by this paper
• Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans

  1983cited by this paper
• Casarett and Doull's Toxicology. The Basic Science of Poisons

  1981cited by this paper
• Induction of liver growth by xenobiotic compounds and other stimuli.

  1974cited by this paper

• Hepatoprotective Potential of Vanillic Acid Against Isoniazid-Rifampicin-Induced Liver Toxicity

  2025cites this paper
• Organoids technology in cancer research: from basic applications to advanced ex vivo models

  2025cites this paper
• Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges.

  2025cites this paper
• Standardization and consensus in the development and application of bone organoids

  2025cites this paper
• Identification of inhibitors from a functional food-based plant Perillae Folium against hyperuricemia via metabolomics profiling, network pharmacology and all-atom molecular dynamics simulations

  2024cites this paper
• A functional human liver tissue model: 3D bioprinted co-culture discoids.

  2024cites this paper
• Potential candidates from a functional food Zanthoxyli Pericarpium (Sichuan pepper) for the management of hyperuricemia: high-through virtual screening, network pharmacology and dynamics simulations

  2024cites this paper
• Synthesis, structural, multitargeted molecular docking analysis of anti-cancer, anti-tubercular, DNA interactions of benzotriazole based macrocyclic ligand.

  2024cites this paper
• Liver organoids and their application in liver cancer research

  2023cites this paper
• Synthesis, Computational, and Anticancer In Vitro Investigations of Aminobenzylnaphthols Derived from 2-Naphtol, Benzaldehydes, and α-Aminoacids via the Betti Reaction

  2023cites this paper
• The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting

  2023cites this paper
• In Vitro and In Silico Investigation of BCI Anticancer Properties and Its Potential for Chemotherapy-Combined Treatments

  2023cites this paper
• In-silico Investigation of Potential Inhibitors of 11-β-Hydroxysteroid Dehydrogenase

  2023cites this paper
• Predicting Hepatotoxicity Associated with Low-Dose Methotrexate Using Machine Learning

  2023cites this paper
• Prediction of drug-induced hepatotoxicity based on histopathological whole slide images.

  2023cites this paper
• Optimisation of the HepaRG cell line model for drug toxicity studies using two different cultivation conditions: advantages and limitations

  2022cites this paper
• Potential Protective and Ameliorate Effects of Sesame Oil and Jojoba Oil Against Potassium Bromate (KBrO 3 )-induced oxidative stress in rats

  2022cites this paper
• Patient-derived Tumour Organoids (PDOs): A Bridge between Cancer Biology and Personalised Therapy.

  2022cites this paper
• The horizon of bone organoid: A perspective on construction and application

  2022cites this paper
• Synthesis, spectra (FT-IR, NMR) investigations, DFT study, in silico ADMET and Molecular docking analysis of 2-amino-4-(4-aminophenyl)thiophene-3-carbonitrile as a potential anti-tubercular agent

  2021cites this paper
• Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach

  2021cites this paper
• Models of Drug Induced Liver Injury (DILI)-Current Issues and Future Perspectives

  2021cites this paper
• Cell-based high-throughput screening for the evaluation of reactive metabolite formation potential.

  2021cites this paper
• Organoid models of the tumor microenvironment and their applications

  2021cites this paper
• Joint Decision-Making Model Based on Consensus Modeling Technology for the Prediction of Drug-Induced Liver Injury

  2021cites this paper
• Tissue engineering, 3D-Bioprinting, morphogenesis modelling and simulation of biostructures: Relevance, underpinning biological principles and future trends

  2021cites this paper
• Microenvironment Activatable Nanoprodrug Based on Gripper-like Cyclic Phenylboronic Acid to Precisely and Effectively Alleviate Drug-induced Hepatitis

  2021cites this paper
• Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities

  2021cites this paper
• Long noncoding RNA LINC00844-mediated molecular network regulates expression of drug metabolizing enzymes and nuclear receptors in human liver cells

  2020cites this paper
• Ensemble Models Based on QuBiLS-MAS Features and Shallow Learning for the Prediction of Drug-Induced Liver Toxicity: Improving Deep Learning and Traditional Approaches.

  2020cites this paper
• A Drug-Induced Liver Injury Prediction Model using Transcriptional Response Data with Graph Neural Network

  2020cites this paper
• Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth

  2019cites this paper
• In Silico Prediction of Drug-Induced Liver Injury Based on Ensemble Classifier Method

  2019cites this paper
• In Silico Approaches to Predict Drug-Transporter Interaction Profiles: Data Mining, Model Generation, and Link to Cholestasis.

  2019cites this paper
• Kidney Safety Assessment: Current Practices in Drug Development.

  2019cites this paper
• Identifying Attributes That Influence In Vitro-to-In Vivo Concordance by Comparing In Vitro Tox21 Bioactivity Versus In Vivo DrugMatrix Transcriptomic Responses Across 130 Chemicals

  2018cites this paper
• Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling

  2018cites this paper
• Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives

  2018cites this paper
• Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites.

  2018cites this paper
• Proteomic Comparison of Various Hepatic Cell Cultures for Preclinical Safety Pharmacology

  2018cites this paper
• A Standardized Collagen-Based Scaffold Improves Human Hepatocyte Shipment and Allows Metabolic Studies over 10 Days

  2018cites this paper
• Organoids in cancer research

  2018cites this paper
• Using Quantitative Systems Toxicology to Investigate Observed Species Differences in CKA-Mediated Hepatotoxicity

  2018cites this paper
• Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes

  2018cites this paper
• In vitro μοντέλο για εκτίμηση της ηπατοτοξικότητας από φάρμακα

  2017cites this paper
• In Vivo Safety of Dichloromethane-Methanolic Extracts of Allium Sativum L. in Swiss Albino Mice

  2017cites this paper
• In vivo Safety of Dichloromethane-Methanolic Extract of Allium sativum in Normal Mice

  2017cites this paper
• Predicting Drug-Induced Cholestasis with the Help of Hepatic Transporters—An in Silico Modeling Approach

  2017cites this paper
• Predicting drug-induced liver injury: The importance of data curation

  2017influential citation
• Evaluation-of-chemically-induced-steatosis indifferent-human-in-vitro-hepatic-systems

  2017cites this paper
• Evaluvation of antihepatotoxic ability of Cassia auriculata (Linn.) Against antituberculosis drug rifampicin induced hepatotoxicity in rats

  2016cites this paper
• Predicting liver toxicity on basis of transporter interaction profiles

  2016cites this paper
• Altération de la dynamique des canalicules biliaires in vitro : une nouvelle approche de la prédiction de la cholestase intrahépatique d'origine médicamenteuse

  2016cites this paper
• Pathogenetic analyses of carbamazepine-induced liver injury in F344 rats focused on immune- and inflammation-related factors.

  2016cites this paper
• Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope.

  2016cites this paper
• Proteomic assessment of potential in vitro hepatotoxicity models

  2016cites this paper
• Target organ profiles in toxicity studies supporting human dosing: Does severity progress with longer duration of exposure?

  2015influential citation
• Preventing Drug-Induced Liver Injury: How Useful Are Animal Models?

  2015cites this paper
• Real-time monitoring of oxygen uptake in hepatic bioreactor shows CYP450-independent mitochondrial toxicity of acetaminophen and amiodarone

  2015cites this paper
• Evaluation of Drug-Induced Liver Injury in an In Vitro Oxidative Stress Inflammation System

  2014cites this paper
• Granulocyte Colony Stimulating Factor Adjuvant Role on the Immunological Response to Hepatitis B Vaccine in Patients With Cirrhosis: A Double Blind Randomized Placebo Controlled Trial

  2014cites this paper
• Toward predictive models for drug-induced liver injury in humans: are we there yet?

  2014cites this paper
• Target organ profiles in toxicity studies supporting human dosing: an assessment of recovery and chronic dosing.

  2014cites this paper
• Alternative Models in Drug Discovery and Development Part I: In Silico and In Vitro Models

  2014cites this paper
• Defining the Relationship between the Bioactivation of Lapatinib by CYP3A and Lapatinib-Induced Hepatotoxicity

  2014cites this paper
• Hepatic Adverse Drug Reactions

  2014cites this paper
• Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes

  2014cites this paper
• Highly expressed protein kinase A inhibitor α and suppression of protein kinase A may potentiate acetaminophen-induced hepatotoxicity.

  2014cites this paper
• Chapter 38 – Regulatory Perspectives

  2013cites this paper
• Target organ toxicities in studies conducted to support first time in man dosing: an analysis across species and therapy areas.

  2013influential citation
• GENERAL INTRODUCTION AND SCOPE OF THIS THESIS

  2013cites this paper
• Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition

  2013cites this paper
• Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist

  2013cites this paper
• Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.

  2013cites this paper
• Toxicologsy : Global and Focussed-Approaches-T " \ NOCase Studies

  2012cites this paper
• Chapter 16 – Biochemical Mechanisms of Drug Toxicity

  2012cites this paper
• Haematological and hepatotoxic potential of onion (Allium cepa) and garlic (Allium sativum) extracts in rats.

  2012cites this paper
• Development of 3-d liver model for drug screening applications

  2012cites this paper
• Hepatoprotective Activity Of Sesame Meal On High Fat Fed Wistar Rats

  2012cites this paper
• Assessment of Compound Hepatotoxicity Using Human Plateable Cryopreserved Hepatocytes in a 1536-Well-Plate Format

  2012cites this paper
• Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.

  2012cites this paper
• Oxygen Measurement During Cell Culture: From Multiwell Plates to Microfluidic Devices

  2011cites this paper
• COMPARATIVE STUDY OF SEVERAL CLASSES OF ORGANIC COMPOUNDS FOR HEPATOTOXICITY . 1 . COVALENT BINDING IMPACT

  2011cites this paper
• A Three-Stage-Integrative Approach for the Identification of Potential Hepatotoxic Compounds From Botanical Products

  2011cites this paper
• Stem cell culture engineering – process scale up and beyond

  2011cites this paper
• Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

  2010cites this paper
• Biocompatible polymer microarrays for cellular high-content screening

  2010cites this paper
• Drug-induced liver injury.

  2010cites this paper
• Predose blood gene expression profiles might identify the individuals susceptible to carbon tetrachloride-induced hepatotoxicity.

  2010cites this paper
• Modifications of Mitochondrial Function by Toxicants

  2010cites this paper
• Drug-Induced Liver Injury Network (DILIN) Prospective Study

  2009cites this paper
• Determination of the key innate genes related to individual variation in carbon tetrachloride-induced hepatotoxicity using a pre-biopsy procedure.

  2009cites this paper
• Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance

  2009cites this paper
• Development of a High-Throughput Human HepG2 Dual Luciferase Assay for Detection of Metabolically Activated Hepatotoxicants and Genotoxicants

  2009cites this paper
• Drug-induced liver injury: insights from genetic studies.

  2009cites this paper
• An Expert System Approach to the Assessment of Hepatotoxic Potential

  2009cites this paper
• Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.

  2009cites this paper
• Drug-induced liver injury : insights from genetic studies Review

  2009cites this paper
• Antihepatotoxic Effects of Boerhaavia diffusa L. on Antituberculosis Drug, Rifampicin Induced Liver Injury in Rats

  2008cites this paper
• Atteintes hépatiques aiguës médicamenteuses

  2008cites this paper